• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Cigna Corporation (Amendment)

    2/14/22 2:34:59 PM ET
    $CI
    Medical Specialities
    Health Care
    Get the next $CI alert in real time by email
    SC 13G/A 1 ci13gadec21.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) Cigna Corp (Name of Issuer) COMMON STOCK (Title of Class of Securities) 125523100 (CUSIP NUMBER) December 31, 2021 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 8,375,875 6. Shared Voting Power* 0 7. Sole Dispositive Power* 17,961,332 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 17,961,332 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 5.4% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: Cigna Corp Item 1(b) Address of Issuer's Principal Executive Offices: 900 COTTAGE GROVE ROAD, BLOOMFIELD, CONNECTICUT 06002 Item 2(a) Name of Person(s) Filing: (1) T. ROWE PRICE ASSOCIATES, INC. ("Price Associates") Item 2(b) Address of Principal Business Office: 100 E. Pratt Street, Baltimore, MD 21202 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 125523100 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class Not Applicable Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Associates does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Associates serves as investment adviser. Any and all discretionary authority which has been delegated to Price Associates may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Associates which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Associates. (2) With respect to securities owned by any one of the T. Rowe Price Funds, only the custodian for each of such Funds, has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. No other person is known to have such right, except that the shareholders of each such Fund participate proportionately in any dividends and distributions so paid. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. ROWE PRICE ASSOCIATES, INC. Date: February 14, 2022 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President 12/31/2021
    Get the next $CI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CI

    DatePrice TargetRatingAnalyst
    5/26/2026$304.00Overweight → Equal Weight
    Barclays
    5/20/2026$302.00Buy → Hold
    Deutsche Bank
    3/12/2026$358.00Mkt Perform → Outperform
    Bernstein
    10/14/2025$370.00Buy
    Goldman
    2/6/2025$323.00Outperform → Mkt Perform
    Bernstein
    6/26/2024$400.00Overweight
    Piper Sandler
    5/30/2024$388.00Outperform
    Robert W. Baird
    3/6/2024$393.00Overweight
    Barclays
    More analyst ratings

    $CI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Holgerson Bryan claimed ownership of 7,693 shares (SEC Form 3)

    3 - Cigna Group (0001739940) (Issuer)

    7/9/26 7:36:18 PM ET
    $CI
    Medical Specialities
    Health Care

    New insider Kautzner Adam claimed ownership of 13,533 shares (SEC Form 3)

    3 - Cigna Group (0001739940) (Issuer)

    7/9/26 7:34:58 PM ET
    $CI
    Medical Specialities
    Health Care

    New insider Sadler Jason D claimed ownership of 34,705 shares (SEC Form 3)

    3 - Cigna Group (0001739940) (Issuer)

    7/9/26 7:33:43 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Cigna Group's Second Quarter 2026 Earnings Release Details

    BLOOMFIELD, Conn., July 7, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2026 financial results on Thursday, July 30, 2026, and will host a conference call the same day. Second quarter 2026 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:             Live Call             (888) 566-1889 (Domestic)             (773) 799-3989 (International)             Passcode: 07302026             Replay             (866) 405-7290 (Domestic) 

    7/7/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    Evernorth Launches Pharmacy Forward: A Simpler, Faster Specialty Pharmacy Experience for Patients Managing Complex Conditions

    New program introduces AI-enabled capabilities to personalize support, streamline prescription processing, and help patients start and stay on therapy with greater ease and confidenceBLOOMFIELD, Conn., July 1, 2026 /PRNewswire/ -- As specialty care becomes more complex, patients need faster, more connected, and personalized support. To help meet that need, Evernorth, the health services division of The Cigna Group (NYSE:CI), today unveiled Pharmacy Forward, a new AI-powered program designed to improve how patients access and experience specialty care. Launching first with Accredo Specialty Pharmacy – which serves patients with chronic and complex specialty conditions through condition-specif

    7/1/26 8:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Foundation Honors David M. Cordani's Leadership with New Grant to Strengthen Military Communities

    New "Courage in Service" grant builds on company's long-standing support for military and veteran communities.BLOOMFIELD, Conn., June 25, 2026 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE:CI), today announced the launch of the David M. Cordani Courage in Service Grant, a new $1.5 million, 10-year commitment to support the health and well-being of military and veteran communities by prioritizing social connection. The grant comes as Cordani, who has served as chief executive officer of The Cigna Group for 17 years, is set to retire as

    6/25/26 10:14:00 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $CI
    SEC Filings

    View All

    $CI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chairman & CEO Cordani David bought $999,916 worth of shares (4,134 units at $241.88) (SEC Form 4)

    4 - Cigna Group (0001739940) (Issuer)

    11/3/25 2:47:56 PM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form 11-K filed by The Cigna Group

    11-K - Cigna Group (0001739940) (Filer)

    6/24/26 4:27:09 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Cigna Group (0001739940) (Filer)

    5/13/26 6:01:44 AM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form 144 filed by The Cigna Group

    144 - Cigna Group (0001739940) (Subject)

    5/12/26 4:18:20 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group downgraded by Barclays with a new price target

    Barclays downgraded The Cigna Group from Overweight to Equal Weight and set a new price target of $304.00

    5/26/26 8:44:05 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded The Cigna Group from Buy to Hold and set a new price target of $302.00

    5/20/26 8:05:39 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group upgraded by Bernstein with a new price target

    Bernstein upgraded The Cigna Group from Mkt Perform to Outperform and set a new price target of $358.00

    3/12/26 8:38:26 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Leadership Updates

    Live Leadership Updates

    View All

    The Cigna Group Foundation Honors David M. Cordani's Leadership with New Grant to Strengthen Military Communities

    New "Courage in Service" grant builds on company's long-standing support for military and veteran communities.BLOOMFIELD, Conn., June 25, 2026 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE:CI), today announced the launch of the David M. Cordani Courage in Service Grant, a new $1.5 million, 10-year commitment to support the health and well-being of military and veteran communities by prioritizing social connection. The grant comes as Cordani, who has served as chief executive officer of The Cigna Group for 17 years, is set to retire as

    6/25/26 10:14:00 AM ET
    $CI
    Medical Specialities
    Health Care

    Kayne Anderson Energy Infrastructure Fund Announces Appointment of Michael J. Hennigan as New Independent Director

    HOUSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the "Company" or "KYN") announced today the appointment of Michael J. Hennigan as an independent director of the Company, effective immediately. Following the retirements of William R. Cordes and Barry R. Pearl earlier this year, the appointment of Mr. Hennigan brings the Company's Board to six members, five of whom are independent. Michael J. Hennigan is a highly accomplished energy executive, with several decades of leadership experience in the refining and midstream sectors. Mr. Hennigan most recently served as Executive Chairman of Marathon Petroleum Corporation (NYSE:MPC) and MPLX LP (NYSE:MPLX

    5/12/26 4:20:00 PM ET
    $CI
    $KYN
    $MPC
    Medical Specialities
    Health Care
    Finance/Investors Services
    Finance

    The Cigna Group Announces President & COO Brian Evanko to Succeed David M. Cordani as Chief Executive Officer

    Cordani to retire as chief executive officer on July 1, 2026, and will serve as executive chair of The Cigna Group Board of DirectorsEvanko elected to the company's Board of DirectorsCompany reaffirms 2026 Financial OutlookBLOOMFIELD, Conn., March 3, 2026 /PRNewswire/ -- The Cigna Group (NYSE: CI) today announced that David M. Cordani will retire as chief executive officer effective July 1, 2026, and become executive chair of The Cigna Group's Board of Directors. Brian Evanko, current president and chief operating officer, will succeed Cordani as CEO. Throughout his tenure—inclu

    3/3/26 7:30:00 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Financials

    Live finance-specific insights

    View All

    The Cigna Group's Second Quarter 2026 Earnings Release Details

    BLOOMFIELD, Conn., July 7, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2026 financial results on Thursday, July 30, 2026, and will host a conference call the same day. Second quarter 2026 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:             Live Call             (888) 566-1889 (Domestic)             (773) 799-3989 (International)             Passcode: 07302026             Replay             (866) 405-7290 (Domestic) 

    7/7/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Reports Strong First Quarter 2026 Results, Raises 2026 Outlook

    Total revenues for the first quarter 2026 increased 5% to $68.5 billionShareholders' net income for the first quarter 2026 was $1.7 billion, or $6.26 per shareAdjusted income from operations1 for the first quarter 2026 was $2.1 billion, or $7.79 per share2026 outlook2 for adjusted income from operations1,2 increased to at least $30.35 per share2BLOOMFIELD, Conn., April 30, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported first quarter 2026 results, reflecting growth across its diversified portfolio of businesses."We continue to improve how people experience health care, leveraging innovation and technology to make it more personalized, more transparent and

    4/30/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Declares Quarterly Dividend

    BLOOMFIELD, Conn., April 22, 2026 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.56 per share of its common stock, payable on June 18, 2026, to shareholders of record as of the close of business on June 4, 2026. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services mar

    4/22/26 4:30:00 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by The Cigna Group

    SC 13G - Cigna Group (0001739940) (Subject)

    11/12/24 9:55:14 AM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by The Cigna Group (Amendment)

    SC 13G/A - Cigna Group (0001739940) (Subject)

    2/13/24 5:02:29 PM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by The Cigna Group (Amendment)

    SC 13G/A - Cigna Group (0001739940) (Subject)

    2/9/24 8:50:20 AM ET
    $CI
    Medical Specialities
    Health Care